Han Eunkyung, Choi Hye Yeon, Kwon Hyun Jung, Chung Yul Ri, Shin Hee-Chul, Kim Eun-Kyu, Suh Koung Jin, Kim Se Hyun, Kim Jee Hyun, Park So Yeon
Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi, Republic of Korea.
Pathology Center, Seegene Medical Foundation, Seoul, Republic of Korea.
Breast Cancer Res. 2024 Dec 6;26(1):180. doi: 10.1186/s13058-024-01932-4.
The tumor immune microenvironment, particularly tumor-infiltrating lymphocytes (TILs), plays a critical role in disease progression and treatment response in triple-negative breast cancers (TNBCs). This study was aimed to characterize the composition of TILs and investigate their clinicopathological and prognostic significance with a special focus on the spatial distribution of TILs in TNBCs.
We analyzed TNBC samples through PanCancer Immune Profiling using NanoString nCounter assays to identify immune-related genes that are expressed differentially in relation to TIL levels and evaluated protein expression of selected markers through immunohistochemical staining on tissue microarrays. For a comprehensive assessment of the expression of cytotoxic T lymphocyte (CTL) and natural killer (NK) cell markers, a CTL-NK score was devised based on CD8, CD56, CD57, GNLY, and GZMB TIL levels.
Gene expression analysis revealed significant upregulation of CTL and NK cell-associated genes including GNLY, KLRC2, and GZMB in TIL-high TNBCs. Immunohistochemical validation confirmed that TNBCs with higher TILs had a greater amount of CD56, CD57, GNLY, and GZMB TILs not only in absolute number but also in proportion relative to CD4 or CD8 TILs. High TIL and its subset (CD4, CD8, CD56, CD57, GNLY, and GZMB TIL) infiltration correlated with favorable clinicopathological features of tumor. In survival analysis, high CTL-NK score was found to be an independent prognostic factor for better disease-free survival (DFS) of the patients. Furthermore, uniformly high TIL infiltration was linked to better DFS, whereas cases with heterogeneous TIL infiltration showed no difference in survival compared to those with uniformly low TIL infiltration.
Our study showed that CTL and NK cell-associated gene expression and protein levels differ significantly according to TIL levels and that CTL-NK score and distribution of TILs within tumors have a prognostic value. These findings emphasize the importance of CTLs and NK cells as well as the spatial uniformity of TIL infiltration in clinical outcome of TNBC patients, providing valuable insights for refining prognostic assessments and guiding immunotherapeutic strategies.
肿瘤免疫微环境,尤其是肿瘤浸润淋巴细胞(TILs),在三阴性乳腺癌(TNBCs)的疾病进展和治疗反应中起着关键作用。本研究旨在描述TILs的组成,并特别关注TNBCs中TILs的空间分布,探讨其临床病理意义和预后意义。
我们通过使用NanoString nCounter分析的泛癌免疫谱分析TNBC样本,以鉴定与TIL水平相关的差异表达免疫相关基因,并通过组织微阵列上的免疫组织化学染色评估选定标志物的蛋白表达。为了全面评估细胞毒性T淋巴细胞(CTL)和自然杀伤(NK)细胞标志物的表达,基于CD8、CD56、CD57、颗粒溶素(GNLY)和颗粒酶B(GZMB)TIL水平设计了CTL-NK评分。
基因表达分析显示,在TIL高的TNBCs中,CTL和NK细胞相关基因(包括GNLY、杀伤细胞凝集素样受体亚家族C成员2(KLRC2)和GZMB)显著上调。免疫组织化学验证证实,TILs较高的TNBCs不仅CD56、CD57、GNLY和GZMB TILs的绝对数量更多,而且相对于CD4或CD8 TILs的比例也更高。高TIL及其亚群(CD4、CD8、CD56、CD57、GNLY和GZMB TIL)浸润与肿瘤的良好临床病理特征相关。在生存分析中,发现高CTL-NK评分是患者无病生存期(DFS)更好的独立预后因素。此外,TIL均匀高浸润与更好的DFS相关,而异质性TIL浸润的病例与均匀低TIL浸润的病例相比,生存率无差异。
我们的研究表明,CTL和NK细胞相关基因表达和蛋白水平根据TIL水平有显著差异,并且CTL-NK评分和肿瘤内TIL的分布具有预后价值。这些发现强调了CTL和NK细胞以及TIL浸润的空间均匀性在TNBC患者临床结局中的重要性,为完善预后评估和指导免疫治疗策略提供了有价值的见解。